H.C. Wainwright Reaffirms Buy Rating on AngioDynamics (ANGO) After Strong Q1 Performance
AngioDynamics, Inc. (NASDAQ:ANGO) is one of billionaire Steve Cohen’s small-cap stock picks with huge upside potential. On October 6, H.C.
Angiodynamics Inc (ANGO)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Divisadero Street Capital William Zolezzi | 3,678,125 | $41,084,656 | +9% | 1.79% |
| 2. | Point72 Asset Management Steve Cohen | 2,558,802 | $28,581,816 | +32% | 0.05% |
| 3. | Millennium Management Israel Englander | 1,793,152 | $20,029,508 | +29% | 0.01% |
| 4. | Armistice Capital Steven Boyd | 1,636,000 | $18,274,120 | +8% | 0.27% |
| 5. | Bastion Asset Management Charles Haggar, Mathieu Boisvert, And Michael Gentile | 1,264,003 | $13,442,327 | +32% | 7.74% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $11.81 | 10,000 | $118,100.00 | 93,597 | 2025-10-21 | Filing | |
| $11.16 | 890 | $9,932.40 | 256,629 | 2025-10-13 | Filing | |
| $11.15 | 10,000 | $111,500.00 | 882,529 | 2025-10-09 | Filing | |
| $6.08 | 100 | $608.00 | 45,877 | 2024-10-10 | Filing | |
| $6.09 | 768 | $4,677.12 | 45,777 | 2024-10-07 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $12.31 | 4,060 | $49,978.60 | 41,817 | 2025-01-16 | Filing | |
| $12.95 | 4,633 | $59,997.35 | 19,189 | 2023-01-31 | Filing | |
| $22.44 | 5,000 | $112,200.00 | 23,822 | 2022-07-29 | Filing | |
| $22.44 | 3,513 | $78,831.72 | 22,874 | 2022-04-28 | Filing | |
| $23.26 | 1,299 | $30,214.74 | 79,704 | 2022-04-12 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,474,722 | $38,812,645 | 0% | |
| 2. | 2,570,506 | $28,712,561 | 0.7% | |
| 3. | 2,364,146 | $26,407,511 | 0% | |
| 4. | 1,319,552 | $14,739,396 | 0.2% | |
| 5. | 1,155,666 | $12,906,789 | 0% |
News See All
Billionaire Steve Cohen's 10 Small-Cap Stock Picks with Huge Upside Potential
Known for speed, agility, and a high-risk, high-reward investment approach, Steve Cohen is one of the most successful hedge fund managers on Wall Street.
AngioDynamics, Inc. (NASDAQ:ANGO) Q4 2025 Earnings Call Transcript
Operator: Good morning, and welcome to the AngioDynamics Fiscal Year 2025 Fourth Quarter Earnings Call. At this time, all participants are in listen-only mode.
AngioDynamics, Inc. (NASDAQ:ANGO) Q3 2025 Earnings Call Transcript
Operator: Good morning, and welcome to the AngioDynamics Fiscal Year 2025 Third Quarter Earnings Call. At this time, all participants are in a listen-only mode.
AngioDynamics, Inc. (NASDAQ:ANGO) Q2 2025 Earnings Call Transcript
Operator: Good morning. Welcome to the AngioDynamics Fiscal Year 2025 Second Quarter Earnings Call. At this time, all participants are in a listen-only mode.
AngioDynamics, Inc. (NASDAQ:ANGO) Q1 2025 Earnings Call Transcript
Operator: Good morning and welcome to the AngioDynamics Fiscal Year 2025 First Quarter Earnings Call. At this time all participants are in listen-only mode.
AngioDynamics, Inc. (NASDAQ:ANGO) Q4 2024 Earnings Call Transcript
Operator: Good morning and welcome to the AngioDynamics fiscal year 2024 Fourth Quarter Earnings Call. At this time, all participants are in a listen-only mode.
5 Micro-Cap Healthcare Stocks Insiders Are Buying
This article presents an overview of 5 Micro-Cap Healthcare Stocks Insiders Are Buying. For a detailed overview of such stocks read our article, 10 Micro-Cap Healthcare Stocks Insiders Are Buying...
AngioDynamics, Inc. (NASDAQ:ANGO) Q3 2024 Earnings Call Transcript
AngioDynamics, Inc. misses on earnings expectations. Reported EPS is $-0.16 EPS, expectations were $-0.14. AngioDynamics, Inc.
AngioDynamics, Inc. (NASDAQ:ANGO) Q2 2024 Earnings Call Transcript
AngioDynamics, Inc. beats earnings expectations. Reported EPS is $-0.05, expectations were $-0.09.